Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-08

Clinical Trial Update: Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients [Phase 3]

View source ↗

Summary

Phase IIIB pediatric trial assessing atazanavir with ritonavir in HIV-infected children has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATAZANAVIR (atazanavir)
  • Ritonavir (Ritonavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV | Phase 3 | Status: COMPLETED | Results posted: 2016-02-08